PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer

Miguel Martín, Aleix Prat, Álvaro Rodríguez-Lescure, Rosalía Caballero, Mark T.W. Ebbert, Blanca Munárriz, Manuel Ruiz-Borrego, Roy R.L. Bastien, Carmen Crespo, Carole Davis, César A. Rodríguez, José M. López-Vega, Vicente Furió, Ana M. García, Maribel Casas, Matthew J. Ellis, Donald A. Berry, Brandelyn N. Pitcher, Lyndsay Harris, Amparo RuizEric Winer, Clifford Hudis, Inge J. Stijleman, David P. Tuck, Eva Carrasco, Charles M. Perou, Philip S. Bernard

Research output: Contribution to journalArticlepeer-review

86 Scopus citations

Fingerprint

Dive into the research topics of 'PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology